Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma.

Vandana BatraAjami GikandiBruce PawelDaniel MartinezM Meaghan GrangerAraz MarachelianJulie R ParkJohn M Maris Kieuhoa T Vo Katherine K Matthay Steven G DuBois

Published in: Pediatric blood & cancer (2023)

I-MIBG therapy in patients with relapsed/refractory neuroblastoma. Increased VMAT2 protein expression is associated with a more differentiated disease phenotype.

Keyphrases

acute lymphoblastic leukemia
acute myeloid leukemia
hodgkin lymphoma
multiple myeloma
diffuse large b cell lymphoma
poor prognosis
stem cells
bone marrow
cell therapy
smoking cessation